Acquisition opportunity Nexgen Pharma was acquired by LGM Pharma in 2020, indicating a potential integration of contract development and manufacturing services with an established distribution and customer base. This suggests sales opportunities to consolidate CRO/CMO services, fill gaps in formulation development, and expand capabilities under new ownership.

Contract manufacturing focus As a specialty pharmaceutical manufacturer offering Rx, OTC, and custom dietary supplement formulations, Nexgen Pharma presents cross-sell potential for end-to-end manufacturing services, scale-up capabilities, and regulatory-compliant packaging solutions to both legacy clients and new buyers in the pharma and dietary supplement spaces.

Quality and experience With over 80 years of manufacturing experience and a stated rigorous commitment to quality and customer service, there is an opportunity to position premium, high-reliability manufacturing partnerships to pharma brands seeking robust QA, GMP compliance, and proven track records for complex products.

Mid-market sizing The company operates with 51-200 employees and reported revenue in the 100M–250M range, indicating mid-market scale. Sales strategies can target mid-size pharma and blended lifestyle brands seeking reliable contract manufacturing partnerships without the complexity of large incumbents.

Digital enablement Current tech footprint includes cloud hosting and CMS tools (AWS, WordPress, WooCommerce) suggesting opportunities to modernize digital catalogs, streaming product development capabilities, or client portals for faster RFQs, quoting, and project tracking to improve sales cycles.